首页> 外国专利> ANTIBODIES AGAINST PHOSPHORYLCHOLINE IN COMBINATION THERAPY WITH BIOLOGIC AGENTS

ANTIBODIES AGAINST PHOSPHORYLCHOLINE IN COMBINATION THERAPY WITH BIOLOGIC AGENTS

机译:与生物制剂联合治疗抗磷脂酰胆碱的抗体

摘要

Antibodies against PC, PC conjugate or bioactive components and/or fragments thereof for use in combination therapy with one or more biologic agents and/or stem cells are disclosed, as well as compositions comprising the antibodies in combination with one or more biologic agents and/or stem cells. Also disclosed are PC conjugates, PC or bioactive components and/or parts/fragments thereof for use in activation immunotherapy prior to or in combination with treatment with biologic agents and/or stem cells for curing, treating, preventing, and/or reducing the risk of developing auto-immune diseases, chronic inflammatory diseases, and cancer diseases, as well as compositions comprising them in combination with biologic agents and/or stem cells.
机译:公开了用于与一种或多种生物剂和/或干细胞联合治疗的抗PC,PC缀合物或生物活性成分和/或其片段的抗体,以及包含与一种或多种生物剂和/或抗体组合的抗体的组合物或干细胞。还公开了在生物试剂和/或干细胞的治疗之前或与之结合以用于活化,治疗,预防和/或降低风险的活化免疫疗法中使用的PC缀合物,PC或生物活性成分和/或其部分/片段。自身免疫疾病,慢性炎性疾病和癌症疾病的发展,以及包含它们与生物制剂和/或干细胞的组合物。

著录项

  • 公开/公告号US2020262906A1

    专利类型

  • 公开/公告日2020-08-20

    原文格式PDF

  • 申请/专利权人 ATHERA BIOTECHNOLOGIES AB;

    申请/专利号US202016868323

  • 发明设计人 JOHAN FROSTEGÅRD;

    申请日2020-05-06

  • 分类号C07K16/24;C07K16/18;C07K14/525;A61K39/395;A61K35/28;C07K16/28;

  • 国家 US

  • 入库时间 2022-08-21 11:25:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号